Cardiomyopathies Clinical Trial
Official title:
Imaging Cardiac Phenotype of SARS-Cov-2 (Covid19) Infected Patients
The effects of severe acute respiratory syndrome SARS-Cov-2 (Covid-19) on the myocardium and their role in the clinical course of infected patients are still unknown. Epidemiological studies report biological myocardial involvement in 10 to 25% of cases. The objective of this study is to cardiac phenotype using comprehensive cardiac imaging tools of patients infected with Covid 19 in order to explore the functional impact of the infection on the myocardium.
A large population of Covid 19 infected patients of different ages and severity levels will be explored by transthoracic echocardiography with measurement of myocardial functional parameters such as ejection fraction, longitudinal strain and relaxation parameters and will be compared to an uninfected population paired for age and sex. Patients with biological myocardial involvement will be followed to determine the evolution of their myocardial functional parameters during the course of the infection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05428787 -
Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing
|
N/A | |
| Not yet recruiting |
NCT05567445 -
Outcome of Cardiomyopathic Adults Admission in ICU.
|
||
| Completed |
NCT02555527 -
Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment
|
N/A | |
| Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
| Recruiting |
NCT05552521 -
Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
|
||
| Recruiting |
NCT04166331 -
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
|
Phase 3 | |
| Terminated |
NCT06331507 -
Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch
|
N/A | |
| Completed |
NCT01953523 -
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
|
N/A | |
| Recruiting |
NCT04695119 -
Sepsis in the ICU-II
|
||
| Completed |
NCT03228966 -
Ped HIV - Echo Study: Kenya
|
||
| Not yet recruiting |
NCT06348732 -
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings
|
||
| Recruiting |
NCT05556369 -
Genetic Characterization of Cardiomyopathies (POLICARDIOMIO2021)
|
||
| Recruiting |
NCT04520646 -
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
|
N/A | |
| Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
| Completed |
NCT04323852 -
Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?
|
Phase 4 | |
| Completed |
NCT03527381 -
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT02462213 -
Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
|
N/A | |
| Active, not recruiting |
NCT00418041 -
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
|
N/A | |
| Not yet recruiting |
NCT06091475 -
Therapy to Maintain Remission in Dilated Cardiomyopathy
|
N/A | |
| Recruiting |
NCT03317964 -
Genetic Basis of Pacing-induced Cardiomyopathy
|